PT1105503E - Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada - Google Patents
Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificadaInfo
- Publication number
- PT1105503E PT1105503E PT99953535T PT99953535T PT1105503E PT 1105503 E PT1105503 E PT 1105503E PT 99953535 T PT99953535 T PT 99953535T PT 99953535 T PT99953535 T PT 99953535T PT 1105503 E PT1105503 E PT 1105503E
- Authority
- PT
- Portugal
- Prior art keywords
- alfal
- betal
- soluvel
- guanililciclase
- hsgc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19837015A DE19837015C2 (de) | 1998-08-14 | 1998-08-14 | Isolierte und gereinigte humane lösliche Guanylylcyclase alpha1/beta1 (hsGCalpha1/beta1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1105503E true PT1105503E (pt) | 2005-03-31 |
Family
ID=7877618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99953535T PT1105503E (pt) | 1998-08-14 | 1999-08-16 | Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6849438B1 (pt) |
| EP (1) | EP1105503B1 (pt) |
| JP (1) | JP2002522083A (pt) |
| AT (1) | ATE282704T1 (pt) |
| AU (1) | AU763515B2 (pt) |
| CA (1) | CA2339529C (pt) |
| DE (2) | DE19837015C2 (pt) |
| ES (1) | ES2229779T3 (pt) |
| NZ (1) | NZ509918A (pt) |
| PT (1) | PT1105503E (pt) |
| WO (1) | WO2000009711A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19944226A1 (de) | 1999-09-15 | 2001-03-29 | Aventis Pharma Gmbh | Verfahren zum Nachweis von oxidierten Formen der löslichen Guanylatzyklase und Verfahren zum Screening nach Aktivatoren der löslichen Guanylatzyklase mit oxidiertem Hämeisen |
| DE10225144A1 (de) * | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| IN2013MN00600A (pt) | 2006-05-22 | 2015-06-12 | Univ California |
-
1998
- 1998-08-14 DE DE19837015A patent/DE19837015C2/de not_active Expired - Lifetime
-
1999
- 1999-08-16 DE DE59911103T patent/DE59911103D1/de not_active Expired - Lifetime
- 1999-08-16 AU AU10274/00A patent/AU763515B2/en not_active Expired
- 1999-08-16 US US09/762,767 patent/US6849438B1/en not_active Expired - Lifetime
- 1999-08-16 AT AT99953535T patent/ATE282704T1/de active
- 1999-08-16 CA CA2339529A patent/CA2339529C/en not_active Expired - Lifetime
- 1999-08-16 EP EP99953535A patent/EP1105503B1/de not_active Expired - Lifetime
- 1999-08-16 NZ NZ509918A patent/NZ509918A/en not_active IP Right Cessation
- 1999-08-16 JP JP2000565146A patent/JP2002522083A/ja active Pending
- 1999-08-16 WO PCT/DE1999/002601 patent/WO2000009711A2/de active IP Right Grant
- 1999-08-16 PT PT99953535T patent/PT1105503E/pt unknown
- 1999-08-16 ES ES99953535T patent/ES2229779T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU1027400A (en) | 2000-03-06 |
| AU763515B2 (en) | 2003-07-24 |
| DE19837015A1 (de) | 2000-02-24 |
| EP1105503A2 (de) | 2001-06-13 |
| WO2000009711A8 (de) | 2000-03-30 |
| DE19837015C2 (de) | 2003-03-20 |
| ES2229779T3 (es) | 2005-04-16 |
| CA2339529C (en) | 2012-04-24 |
| DE59911103D1 (de) | 2004-12-23 |
| US6849438B1 (en) | 2005-02-01 |
| JP2002522083A (ja) | 2002-07-23 |
| WO2000009711A2 (de) | 2000-02-24 |
| ATE282704T1 (de) | 2004-12-15 |
| NZ509918A (en) | 2003-10-31 |
| CA2339529A1 (en) | 2000-02-24 |
| WO2000009711A3 (de) | 2000-06-15 |
| EP1105503B1 (de) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
| WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| TR200102733T2 (tr) | IL-18 kaynaklı rahatsızlıkların tedavisinde faydalı rekombinant IL-18 antagonistleri | |
| TR200101859T2 (tr) | Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler | |
| WO2004043361A3 (en) | Compositions and methods for the treatment of natural killer cell related diseases | |
| TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
| ATE385806T1 (de) | Fusionsproteine | |
| DE69928093D1 (de) | Kombinationspräparat enthaltend monozyten-abgeleitete zellen zur behandlung von neoplastischen oder infektiösen erkrankungen | |
| AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
| AU9363398A (en) | Hepatitis c receptor protein cd81 | |
| YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
| DE69725754D1 (de) | Eingekapselte Antikörper-produzierende Zellen | |
| PT1105503E (pt) | Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada | |
| WO2001040465A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
| UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
| WO2001066740A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2001072334A3 (en) | Methods for treating disease with antibodies to cxcr3 | |
| TR200003352T2 (tr) | Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler | |
| AU7079300A (en) | Compositions and methods for the treatment of immune related diseases |